Global Molecular Point of care Testing (Using NAAT) Market to 2032
Overview
The Global Molecular Point of care Testing (Using NAAT) Market is expected to reach a 76.48 USD Billion by 2032 and is projected to grow at a CAGR of 8.02% from 2025 to 2032.
Global Molecular Point of care Testing (Using NAAT) Market 2018-2032 USD Billion
Global Molecular Point of care Testing (Using NAAT) Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 36.42 USD Billion
- Projected Market Size (2032): 76.48 USD Billion
- CAGR (2025-2032): 8.02%
Key Findings of Global Molecular Point of care Testing (Using NAAT) Market
- The Global Molecular Point of care Testing (Using NAAT) Market was valued at 76.48 USD Billion in 2024.
- The Global Molecular Point of care Testing (Using NAAT) Market is likely to grow at a CAGR of 8.02% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Prescription-Based Testing in Mode of Testing Segment accounted for the largest share of the market with a revenue of 34.31 USD Billion
- The fastest growing segment Direct Sales in Distribution Channel Segment grew Fastest with a CAGR of 8.85% during the forecast period from 2024 to 2032.
Global Molecular Point of care Testing (Using NAAT) Market Scope
- Assisted Living Facilities
- Homecare
- Others
- Ambulatory Center
- Clinics
- Hospital
- Laboratories
- Others
- Gastrointestinal Tract Infections Testing
- Sexually Transmitted Infection (STI) Testing
- Respiratory Infections Testing
- Instruments
- Consumables & Reagents
- Online Sales
- Third Party Distributor
- Direct Sales
- OTC Testing
- Prescription-Based Testing
Global Molecular Point of care Testing (Using NAAT) Market Data Coverage Insights
Study Period | 2024-2032 |
Base Year | 2022 |
Unit | Revenue in USD Billion |
Market Value in 2024 | 36.42 USD Billion |
Market Value in 2032 | 76.48 USD Billion |
CAGR (2025-2032) | 8.02% |
Historic Data | 2016-2023 |
Market Segments Covered | End User, Indication, Product, Distribution Channel, Mode of Testing |
Regional Insights:
-
Leading Market (2024-2032): Global, leading in terms of revenue 36.42 USD Billion in 2024
- Key Country: U.S., leading in terms of revenue with value of 19,017.32 USD Million in 2024.
Segments and Scope
-
Global Molecular Point of care Testing (Using NAAT) Market to 2032, By End User
- Laboratories is the largest segment in Global Molecular Point of care Testing (Using NAAT) Market to 2032 with a revenue of 26.51 USD Billion in the year 2024.
- Laboratories is the Fastest growing segment in Global Molecular Point of care Testing (Using NAAT) Market to 2032 with a Growth rate of 8.49 % in forecast period 2025-2032.
-
Global Molecular Point of care Testing (Using NAAT) Market to 2032, By Indication
- Respiratory Infections Testing is the largest segment in Global Molecular Point of care Testing (Using NAAT) Market to 2032 with a revenue of 22.91 USD Billion in the year 2024.
- Respiratory Infections Testing is the Fastest growing segment in Global Molecular Point of care Testing (Using NAAT) Market to 2032 with a Growth rate of 8.75 % in forecast period 2025-2032.
-
Global Molecular Point of care Testing (Using NAAT) Market to 2032, By Product
- Consumables & Reagents is the largest segment in Global Molecular Point of care Testing (Using NAAT) Market to 2032 with a revenue of 28.40 USD Billion in the year 2024.
- Consumables & Reagents is the Fastest growing segment in Global Molecular Point of care Testing (Using NAAT) Market to 2032 with a Growth rate of 8.15 % in forecast period 2025-2032.
-
Global Molecular Point of care Testing (Using NAAT) Market to 2032, By Distribution Channel
- Direct Sales is the largest segment in Global Molecular Point of care Testing (Using NAAT) Market to 2032 with a revenue of 22.74 USD Billion in the year 2024.
- Direct Sales is the Fastest growing segment in Global Molecular Point of care Testing (Using NAAT) Market to 2032 with a Growth rate of 8.85 % in forecast period 2025-2032.
-
Global Molecular Point of care Testing (Using NAAT) Market to 2032, By Mode of Testing
- Prescription-Based Testing is the largest segment in Global Molecular Point of care Testing (Using NAAT) Market to 2032 with a revenue of 34.31 USD Billion in the year 2024.
- Prescription-Based Testing is the Fastest growing segment in Global Molecular Point of care Testing (Using NAAT) Market to 2032 with a Growth rate of 8.19 % in forecast period 2025-2032.
Global Molecular Point of care Testing (Using NAAT) Market Company Share Analysis
Company Name |
![]() |
||
Thermo Fisher Scientific Inc. | |||
Abbott | |||
Hologic, Inc. | |||
Danaher | |||
F. Hoffmann-La Roche Ltd. |

Global Molecular Point of care Testing (Using NAAT) Market Geographical Sales Distribution, 2018-2032 USD Billion

Global Molecular Point of care Testing (Using NAAT) Market Company Profiling

Industry Related Reports
Frequently Asked Questions
Coming Soon....
Global Molecular Point of care Testing (Using NAAT) Market Scope
- Assisted Living Facilities
- Homecare
- Others
- Ambulatory Center
- Clinics
- Hospital
- Laboratories
- Others
- Gastrointestinal Tract Infections Testing
- Sexually Transmitted Infection (STI) Testing
- Respiratory Infections Testing
- Instruments
- Consumables & Reagents
- Online Sales
- Third Party Distributor
- Direct Sales
- OTC Testing
- Prescription-Based Testing
Frequently Asked Questions
Global Molecular Point of care Testing (Using NAAT) Market Company Profiling

Frequently Asked Questions
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.